Invention Grant
- Patent Title: Bicyclic heterocyclic compound
-
Application No.: US15769835Application Date: 2016-10-21
-
Publication No.: US10793582B2Publication Date: 2020-10-06
- Inventor: Masahiro Okuyama , Kenji Fukunaga , Kenji Usui , Norimitsu Hayashi , Daisuke Iijima , Hideki Horiuchi , Nobuaki Fujimoto
- Applicant: MITSUBISHI TANABE PHARMA CORPORATION
- Applicant Address: JP Osaka-Shi
- Assignee: MITSUBISHI TANABE PHARMA CORPORATION
- Current Assignee: MITSUBISHI TANABE PHARMA CORPORATION
- Current Assignee Address: JP Osaka-Shi
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3d39f968
- International Application: PCT/JP2016/081368 WO 20161021
- International Announcement: WO2017/069275 WO 20170427
- Main IPC: A61K31/437
- IPC: A61K31/437 ; A61K31/5377 ; A61K31/519 ; A61K31/553 ; A61K31/4985 ; C07D513/04 ; C07D471/04 ; C07D519/00 ; A61P25/28 ; A61P25/18 ; C07D487/04 ; C07D498/04 ; A61P25/24
Abstract:
Provided are a novel compound having a superior inhibitory action on KAT-II, a production method thereof, use thereof, and a pharmaceutical composition containing the aforementioned compound and the like.A compound represented by the formula (I) or a pharmacologically acceptable salt thereof. wherein each symbol is as defined in the DESCRIPTION.
Public/Granted literature
- US20190233438A1 NOVEL BICYCLIC HETEROCYCLIC COMPOUND Public/Granted day:2019-08-01
Information query
IPC分类:
